Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
Status:
Completed
Trial end date:
2020-09-18
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if minocycline can help reduce the
symptoms reported by patients with MM who receive therapy with lenalidomide.
Minocycline is an antibiotic and has been shown to interrupt pro-inflammatory cytokine
production, which may help to reduce multiple symptoms.